Position in ABCL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$31,627
+$19,360 QoQ
Shares Held
4,029
+14.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#131
of 150 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. ABCL ranks #58 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in ABCL
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,627 | 4,029 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $12,267 | 3,515 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $11,610 | 3,395 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,621 | 2,708 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,219 | 2,688 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $7,401 | 3,319 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $9,071 | 3,096 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,194 | 1,998 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,270 | 1,105 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $11,180 | 2,468 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $14,092 | 2,468 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,474 | 538 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $2,739 | 424 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $2,269 | 301 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $1,813 | 179 | Shares | Sole | 2023-02-06 | |
| No filing history on record for this holder in this stock. | ||||||